S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

CDT Equity Inc. Common Stock

CDT XNAS
$1.40 +0.38 (+37.15%) ▲ 15-min delayed
Open
$1.42
High
$1.91
Low
$1.27
Volume
106.64M
Market Cap
$4.96M

About CDT Equity Inc. Common Stock

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 4 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $0 $-39,224,000 $-1177.89
FY 2025 $0 $-39,224,000 $-1177.89
Q3 2025 $0 $-7,118,000 $-13.16
Q2 2025 $0 $-6,028,000 $-5.46

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 12, 2026
Calendar →

Get CDT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CDT Equity Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.